Complicating Factors and Leading Practices

Since 2002, more than 20 states have introduced legislation requiring pharmaceutical and medical device manufacturers to disclose payments or exchanges of financial value to physicians and other healthcare professionals (HCPs). While states increasingly pass new and expanded legislation, the federal government is proposing to increase the scale of disclosure substantially. This white paper explores how companies can prepare for 50-state aggregate spend reporting by automating data capture, aggregation and reporting.